/Companies

Epoch Biodesign

London, GB · 80 employees on LinkedIn · 18 known investors

Find your way into Epoch Biodesign

Sign up to see every warm intro you have to Epoch Biodesign

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Epoch Biodesign team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Epoch Biodesign develops enzyme recycling technology powered by AI to break down plastic and textile waste into virgin-grade chemical building blocks. The company serves the fashion, apparel, and automotive industries pursuing textile-to-textile and plastic circularity.

Founders & leadership

JJacob
JacobFounder at Epoch Biodesign Website
JNJacob Nathan
Jacob NathanFounder & CEOFounder at Epoch Biodesign Website
DK
Douglas KellFounder

Investors · 18

Also in the syndicate · 1

Lululemon

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

Companies working in the same space as Epoch Biodesign.

Companies House · registry record

View on Companies House ↗
Registered name
EPOCH BIODESIGN LTD
Company number
11824812
Status
Active
Company type
Private limited company
Incorporated
13 Feb 2019
Registered office
10 Finsbury Square, London, EC2A 1AJ
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Previous names
MELLIZYME BIOTECHNOLOGY LIMITED (2019–2023)
Accounts
last made up to 31 Mar 2025 · next due 31 Dec 2026
Confirmation statement
last made up to 12 Feb 2026 · next due 26 Feb 2027

Current officers · 2

  • Clay Dumas — director, appointed 14 Dec 2021
  • Jacob Leon Nathan — director, appointed 13 Feb 2019

Source: Companies House public register · retrieved 15 Nov 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Frequently asked questions

What does Epoch Biodesign do?
Epoch Biodesign develops enzyme recycling technology powered by AI to break down plastic and textile waste into virgin-grade chemical building blocks. The company serves the fashion, apparel, and automotive industries pursuing textile-to-textile and plastic circularity.
Who founded Epoch Biodesign?
Epoch Biodesign was founded by Jacob, Jacob Nathan.
Who are Epoch Biodesign's investors?
Epoch Biodesign's investors include Extantia Capital, Mundi Ventures, Lowercarbon Capital, Amadeus Capital Partners, Avonmore Developments, BoxGroup, Cambridge Angels group, Jude Gomila and 9 more.
Where is Epoch Biodesign headquartered?
Epoch Biodesign is headquartered in London, GB.